Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121

Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wen Shi Lee, Arnold Reynaldi, Thakshila Amarasena, Miles P. Davenport, Matthew S. Parsons, Stephen J. Kent
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
HIV
Acceso en línea:https://doaj.org/article/099d8252a5c742e2aa9272fa91e71d68
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:099d8252a5c742e2aa9272fa91e71d68
record_format dspace
spelling oai:doaj.org-article:099d8252a5c742e2aa9272fa91e71d682021-11-11T09:18:06ZAnti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT1211664-322410.3389/fimmu.2021.749891https://doaj.org/article/099d8252a5c742e2aa9272fa91e71d682021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.749891/fullhttps://doaj.org/toc/1664-3224Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.Wen Shi LeeArnold ReynaldiThakshila AmarasenaMiles P. DavenportMatthew S. ParsonsMatthew S. ParsonsMatthew S. ParsonsStephen J. KentStephen J. KentFrontiers Media S.A.articleHIVbroadly neutralizing antibodies (bNAb)PGT121anti-drug antibodies (ADA)pigtailed macaqueImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic HIV
broadly neutralizing antibodies (bNAb)
PGT121
anti-drug antibodies (ADA)
pigtailed macaque
Immunologic diseases. Allergy
RC581-607
spellingShingle HIV
broadly neutralizing antibodies (bNAb)
PGT121
anti-drug antibodies (ADA)
pigtailed macaque
Immunologic diseases. Allergy
RC581-607
Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
description Broadly neutralising antibodies (bNAbs) may play an important role in future strategies for HIV control. The development of anti-drug antibody (ADA) responses can reduce the efficacy of passively transferred bNAbs but the impact of ADA is imperfectly understood. We previously showed that therapeutic administration of the anti-HIV bNAb PGT121 (either WT or LALA version) controlled viraemia in pigtailed macaques with ongoing SHIV infection. We now report on 23 macaques that had multiple treatments with PGT121. We found that an increasing number of intravenous doses of PGT121 or human IgG1 isotype control antibodies (2-4 doses) results in anti-PGT121 ADA induction and low plasma concentrations of PGT121. ADA was associated with poor or absent suppression of SHIV viremia. Notably, ADA within macaque plasma recognised another human bNAb 10E8 but did not bind to the variable domains of PGT121, suggesting that ADA were primarily directed against the constant regions of the human antibodies. These findings have implications for the development of preclinical studies examining multiple infusions of human bNAbs.
format article
author Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
author_facet Wen Shi Lee
Arnold Reynaldi
Thakshila Amarasena
Miles P. Davenport
Matthew S. Parsons
Matthew S. Parsons
Matthew S. Parsons
Stephen J. Kent
Stephen J. Kent
author_sort Wen Shi Lee
title Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_short Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_full Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_fullStr Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_full_unstemmed Anti-Drug Antibodies in Pigtailed Macaques Receiving HIV Broadly Neutralising Antibody PGT121
title_sort anti-drug antibodies in pigtailed macaques receiving hiv broadly neutralising antibody pgt121
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/099d8252a5c742e2aa9272fa91e71d68
work_keys_str_mv AT wenshilee antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT arnoldreynaldi antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT thakshilaamarasena antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT milespdavenport antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT matthewsparsons antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT stephenjkent antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
AT stephenjkent antidrugantibodiesinpigtailedmacaquesreceivinghivbroadlyneutralisingantibodypgt121
_version_ 1718439190687907840